JUSTIN DECOUX: Open Payments
NPI 1063865046 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 51 payments from 18 companies in 2025. Trend: 2023 $1,645 · 2024 $1,390 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $198 |
| Novo Nordisk Inc | 8 | $141 |
| PFIZER INC. | 5 | $106 |
| Lilly USA, LLC | 5 | $98 |
| Astellas Pharma US Inc | 4 | $78 |
| Exact Sciences Corporation | 4 | $65 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Dexcom, Inc. | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
Products named: AIRSUPRA, MOUNJARO, Veozah, ELIQUIS, Ozempic, PREVNAR 20, Dexcom G6 Transmitter, JARDIANCE.
Industry payments across TX — which companies pay providers there.
